Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Inventory (2016 - 2019)

Ironwood Pharmaceuticals (IRWD) has disclosed Inventory for 8 consecutive years, with $648000.0 as the latest value for Q4 2019.

  • Quarterly Inventory changed N/A to $648000.0 in Q4 2019 from the year-ago period, while the trailing twelve-month figure was $648000.0 through Dec 2019, changed N/A year-over-year, with the annual reading at $648000.0 for FY2019, N/A changed from the prior year.
  • Inventory hit $648000.0 in Q4 2019 for Ironwood Pharmaceuticals, down from $2.3 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $5.0 million in Q1 2015 to a low of $76000.0 in Q3 2018.
  • Historically, Inventory has averaged $1.4 million across 5 years, with a median of $1.1 million in 2016.
  • Biggest five-year swings in Inventory: crashed 84.13% in 2018 and later surged 2923.68% in 2019.
  • Year by year, Inventory stood at $5.0 million in 2015, then crashed by 78.16% to $1.1 million in 2016, then crashed by 32.01% to $735000.0 in 2017, then crashed by 89.66% to $76000.0 in 2018, then surged by 752.63% to $648000.0 in 2019.
  • Business Quant data shows Inventory for IRWD at $648000.0 in Q4 2019, $2.3 million in Q3 2019, and $1.7 million in Q2 2019.